Clara Baldin

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
We assessed prophylactic or continuous therapy of isavuconazole, posaconazole, or voriconazole in treating pulmonary murine mucormycosis. In the prophylaxis studies, only isavuconazole treatment resulted in significantly improved survival and lowered tissue fungal burden of immunosuppressed mice infected with Rhizopus delemar. In the continuous treatment(More)
During the past 2 decades, mucormycosis has become the third most common invasive fungal infection in patients with hematological malignancies and organ transplantations [1]. This life-threatening disease is caused by ubiquitous fungi in the order Mucorales, predominantly by Rhizopus species including R. delemar and R. oryzae. Other common causative(More)
  • 1